SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-13-042968
Filing Date
2013-02-07
Accepted
2013-02-07 12:56:54
Documents
2
Group Members
ANSBERT GADICKEKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT II LLCMPM ASSET MANAGEMENT II, L.P.MPM ASSET MANAGEMENT INVESTORS 2002 LLCMPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KGMPM BIOVENTURES II, L.P.NICHOLAS GALAKATOS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d479740dsc13ga.htm SC 13G/A 217583
2 EX-99.A d479740dex99a.htm EX-99.A 17638
  Complete submission text file 0001193125-13-042968.txt   237193
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 6174259200
MPM BIOVENTURES II QP LP (Filed by) CIK: 0001264830 (see all company filings)

IRS No.: 043523699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139 6172995000
AVEO PHARMACEUTICALS INC (Subject) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85745 | Film No.: 13581200
SIC: 2834 Pharmaceutical Preparations